chemotherapy
Showing 1 - 25 of 368
Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy
Recruiting
- Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
- Chemotherapy
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jun 6, 2022
Pancreatic Ductal Adenocarcinoma Trial (Thermal Ablation, Chemotherapy)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Thermal Ablation
- Chemotherapy
- (no location specified)
Nov 9, 2022
Gastric Cancer Trial in Shanghai (camrelizumab+chemo, Chemotherapy)
Recruiting
- Gastric Cancer
- camrelizumab+chemotherapy
- Chemotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital
Aug 9, 2022
Relapsed Ovarian Cancer Trial in Hangzhou (Secondary cytoreduction, Chemotherapy)
Recruiting
- Relapsed Ovarian Cancer
- Secondary cytoreduction
- Chemotherapy
-
Hangzhou, Zhejiang, ChinaWomen's Hospital, Zhejiang University School of Medicine
Nov 4, 2022
Solid Tumor Trial in Yantai (NK combined with Chemotherapy, Chemotherapy)
Recruiting
- Solid Tumor
- NK combined with Chemotherapy
- Chemotherapy
-
Yantai, Shandong, ChinaYantai Yuhuangding Hospital
Feb 7, 2022
Solid Tumor Trial in Yantai (DC-CIK combined with Chemotherapy, Chemotherapy)
Recruiting
- Solid Tumor
- DC-CIK combined with Chemotherapy
- Chemotherapy
-
Yantai, Shandong, ChinaYantai Yuhuangding Hospital
Feb 7, 2022
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )
Not yet recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- HLX07
- +3 more
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 23, 2022
Premature Ovarian Failure Trial in Fayoum (Goserelin, Chemotherapy)
Enrolling by invitation
- Premature Ovarian Failure
- Goserelin
- Chemotherapy
-
Fayoum, Mesala, EgyptBeni Suef university
Dec 7, 2021
NSCLC Trial (Chemotherapy, Alflutinib plus chemo)
Not yet recruiting
- NSCLC
- Chemotherapy
- Alflutinib plus chemotherapy
- (no location specified)
Jan 25, 2022
Breast Cancer Trial (Patritumab deruxtecan, Chemotherapy, Letrozole)
Not yet recruiting
- Breast Cancer
- Patritumab deruxtecan
- +2 more
- (no location specified)
Oct 3, 2022
Colorectal Cancer Trial in Hangzhou (Surufatinib, Toripalimab, chemo)
Recruiting
- Colorectal Cancer
- Surufatinib
- +2 more
-
Hangzhou, Zhejiang, ChinaFirst affiliated hospital, Zhejiang University
Feb 26, 2022
NSCLC Metastatic Trial in Chengdu (Camrelizumab, stereotactic body radiation therapy, Chemotherapy)
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Camrelizumab
- +2 more
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital & Institute
Jul 21, 2022
Predicting Biomarker of Gastric Cancer Chemotherapy Response
Recruiting
- Gastric Cancer
- +2 more
- Chemotherapy
-
Daegu, Korea, Republic ofKyungpook National University Medical Canter
Aug 8, 2021
Ovarian Cancer Trial in Tai'an (Bevacizumab, chemo, Fluzoparib)
Recruiting
- Ovarian Cancer
- Bevacizumab
- +2 more
-
Tai'an, Shandong, ChinaThe Second Affiliated Hospital of Shandong First Medical Univers
Dec 24, 2021
Gastric Cancer, Neoadjuvant Chemo Trial in Shanghai (Chemotherapy)
Not yet recruiting
- Gastric Cancer
- Neoadjuvant Chemotherapy
- Chemotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiaotong University School of Medicine
Jul 15, 2021
Rectal Cancer Trial in Mecca (Chemotherapy)
Recruiting
- Rectal Cancer
- Chemotherapy
-
Mecca, Makkah Western, Saudi ArabiaKing Abdullah Medical City, Holy Capital
Apr 5, 2022
Thoracic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (chemo)
Recruiting
- Thoracic Esophageal Squamous Cell Carcinoma
- chemotherapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen Uniersity Cancer Center
Mar 30, 2022
Carcinoma, Pancreatic Ductal Trial in Trondheim (SonoVue, Chemotherapy)
Recruiting
- Carcinoma, Pancreatic Ductal
- SonoVue
- Chemotherapy
-
Trondheim, NorwayDepartment of Radiology, St Olavs Hospital
Dec 29, 2021
Chemotherapy-induced Cognitive Alterations in Recruits With
Active, not recruiting
- Cognition Disorders
- Polyneuropathies
- Chemotherapy
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Aug 13, 2021
Head and Neck Squamous Cell Carcinoma Trial in Montbéliard (Chemotherapy, Stereotactic radiotherapy)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Chemotherapy
- Stereotactic radiotherapy
-
Montbéliard, FranceHôpital Nord Franche Comté
Mar 10, 2022
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)
Not yet recruiting
- Rectal Adenocarcinoma
- +8 more
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal
Recruiting
- Rectal Cancer
- Magnetic resonance guided radiotherapy
- Chemotherapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 9, 2022
ALK Fusion Protein Expression, Adjuvant Therapy, NSCLC Trial (Ensatinib, chemo)
Not yet recruiting
- ALK Fusion Protein Expression
- +2 more
- Ensatinib
- chemotherapy
- (no location specified)
Jan 10, 2022
Colorectal Carcinoma, Chemo, Liver Metastases Trial (Chemotherapy)
Not yet recruiting
- Colorectal Carcinoma
- +2 more
- Chemotherapy
- (no location specified)
Mar 3, 2021
Chemotherapy for Gynecological Malignancy in High-risk Region of
Active, not recruiting
- Gynecological Cancer
- Chemotherapy
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 6, 2021